Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 33 for “"Janus Kinase 2"”.
-
Identification and characterization of different mutations of the Janus kinase 2 gene
Janus kinases belong to the family of cytoplasmic tyrosine kinases. They are mostly<br>receptor-associated. When a ligand binds a receptor, JAKs activate intracellular signalling<br>pathways such as the signal transducers and activators of transcription (STAT) group, which<br>regulate …
-
Identification and characterization of different mutations of the Janus kinase 2 gene
Janus kinases belong to the family of cytoplasmic tyrosine kinases. They are mostly<br>receptor-associated. When a ligand binds a receptor, JAKs activate intracellular signalling<br>pathways such as the signal transducers and activators of transcription (STAT) group, which<br>regulate …
-
Synthesis of Small Molecule Inhibitors of Janus Kinase 2, Phosphodiesterase IV, GABAA and NMDA receptors: Investigation of Mcmurry, Mannich and Chemoenzymatic Strategies
Stilbenoids possess a wide range of biological properties such as, anticancer, antiplatelet aggregation, antiestrogenic, antibacterial, antifungal and antiatherogenic, etc. Owing to these therapeutic values, a great deal of attention attracted in the synthesis of derivatives of stilbenes. During …
-
Elucidating metabolic alterations in myeloproliferative neoplasms: implications for treatment
… three main somatic mutations leading to MPN are Janus Kinase 2 V617F (JAK2V617F), Janus Kinase 2 exon 12 and Calreticulin (CALR). JAK2V617F was the first driver mutation found in MPNs, with a mutation rate of 95%/60%/55% in PV, ET and PMF respectively. Janus Kinase 2 is one of the four Janus …
-
Διαταραχές αιμόστασης σε μυελοϋπερπλαστικά νοσήματα
… treatment characteristics, mutations of the Janus kinase 2 gene (JAK2), the calreticulin gene (CALR), the thrombopoietin gene (MPL) and the polymorphism rs1136410 of poly (ADP-ribose) polymerase-1 (PARP-1).According to ROTEM parameters, patients with ET had a more hypercoagulable status …
-
Cyclophilin A as a molecular switch regulating prolactin receptor mediated signaling, mammary tumorigenesis and metastasis
… its receptor and induces activation of proximal Janus kinase 2 (Jak2) for signal transduction. Here, we sought to determine the role of PRLr-associated peptidyl-prolyl isomerase, cyclophilin A (CypA), in modulating structure/function relationships of the PRLr. It was demonstrated that CypA …
-
Small Molecule Inhibitors of Stat3 Protein as Cancer Therapeutic Agents
… upstream regulators of Stat3 activation (such as Janus kinase 2), direct inhibition of Stat3 protein may offer improved response, larger therapeutic windows for treatment and fewer side effects. The work presented within this thesis is focused on optimizing known Stat3 inhibitor S3I-201, a small …
-
Overcoming Resistance to CDK4/6-targeted Therapy Using JAK2/STAT3 Inhibitor in Triple-Negative Breast Cancer
… of recurrence and metastasis. Cyclin-dependent kinase 4 and 6 (CDK4/6) are major cell cycle regulators that control G1 to S phase transition and aberrant hyperactivation of the CDK4/6 pathway results in uncontrolled cell proliferation. Although three CDK4/6 inhibitors (CDK4/6is) have achieved …
-
Anti-Cancer Activity of Cucurbitacin IIa
… stemming from their inhibitory effects on Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling. Cucurbitacin IIa (Cuc IIa) is the newest compound to be characterized in this family. The purpose of this thesis is to investigate the anti-cancer properties …
-
The Role of Prolactin in the Cellular Response to DNA Damaging Agents
… protein-90 (HSP90), Hsp90alpha, is a prolactin-Janus kinase-2 (Jak2)-signal transducer and activator of transcription-5 (Stat5) regulated gene in breast cancer cells. We have now observed that prolactin increased the viability of breast cancer cells to DNA damaging chemotherapeutics, and Hsp90 …
-
Investigating the dual roles of STRA6 in cell signaling and vitamin A trafficking
… leads to the recruitment and activation of Janus kinase 2 (Jak2) and Signal transducer and activator of transcription 5 (Stat5). Once activated, Stat5 is translocated to the nucleus where it mediates the expression of specific target genes related to differentiation, apoptosis, and …
-
The role of HDAC9 in JAK2V617F-driven myeloproliferative neoplasms
Janus kinase 2 (JAK2) encodes a protein tyrosine kinase that is critical for haematopoiesis. JAK2 functions by modulating signal transduction between the receptor and the JAK-STAT, ERK1/2 and AKT phosphorylation signalling pathways. The mutation, JAK2V617F, loses the ability to inhibit …
-
Molecular Characterization of the von Hippel-Lindau Ubiquitin Ligase
… of erythropoiesis by targeting phosphorylated Janus kinase 2 (JAK2) for ubiquitin-mediated destruction. The malfunction of this ubiquitin ligase explains the excessive erythrocytosis observed in Chuvash polycythemia patients and reveals a novel genetic link between the seemingly distinct genes …
-
Mechanisms of platelet activation in vaccine-induced thrombotic thrombocytopenia and heparin-induced thrombocytopenia
… receptor c-Mpl and signalling through Janus kinase 2 (JAK2), a process that can be blocked by the JAK2 inhibitor, ruxolitinib, and a c-Mpl blocking antibody. Next, it was shown that blockade of the PF4-c-Mpl interaction and downstream signalling could reduce platelet aggregation to sera …
-
Determinants of Growth Hormone Receptor Downregulation
… transport through the Golgi. It has no intrinsic kinase activity. One molecule of GH binding to predimerized GHR on the cell surface induces the receptor conformational change activating the cytoplasmic domainassociated tyrosine kinase, Janus Kinase 2 (JAK2), which phosphorylates GHR, followed by …
-
Erythropoietin Stimulation of Mitochondrial Protein Content - A Potential Mechanism through Direct Binding of Erythropoietin Receptor and AMP-Activated Protein Kinase
… of Epo treatment. Interestingly, inhibition of Janus Kinase 2 (Jak2), the tyrosine kinase associated with Epo receptor, by AG490 elicited a similar decrease in CoxIV to Epo withdrawal even in the presence of Epo. In addition, Epo increased the levels of the mitochondrial biogenesis regulator …
-
Ubiquitination of EpoR and p85 in Ligand Induced EpoR Down-Regulation
… progenitor cells. Epo binding to EpoR activates Janus kinase 2 (JAK2), which phosphorylates cytoplasmic tyrosines of the EpoR. Signaling proteins bind these phosphotyrosines through SH2 domains, leading to the survival and proliferation of erythroid progenitor cells and the differentiation of …
-
The influence of metabolic hormones on lactation
… My work showed that GH signals through the Janus kinase 2 (Jak2)- signal transducer and activator of transcription 5 (STAT5) pathway, while transcriptomic evaluation of GH-treated HC11 cells demonstrated that GH promotes synthesis of milk proteins and proteins associated with lipid …
-
Amphiphilic Cell-Penetrating Hybrid Cyclic-Linear Peptides as a Drug Delivery System
… Silencing of kinesin spindle protein (KSP) and Janus kinase 2 (JAK2) was evaluated in MDA-MB-231 cells in the presence of the peptides. The addition of DOPE significantly enhanced the silencing efficiency for all selected peptides. A chemotherapeutic drug, doxorubicin (Dox) was covalently …
Page 1 of 2